A BAG's life: Every connection matters in cancer

Publication date: Available online 27 January 2020Source: Pharmacology & TherapeuticsAuthor(s): Elena Mariotto, Giampietro Viola, Carlo Zanon, Sanja AveicAbstractThe members of the BCL-2 associated athanogene (BAG) family participate in the regulation of a variety of interrelated physiological processes, such as autophagy, apoptosis, and protein homeostasis. Under normal circumstances, the six BAG members described in mammals (BAG1-6) principally assist the 70 kDa heat-shock protein (HSP70) in protein folding; however, their role as oncogenes is becoming increasingly evident. Deregulation of the BAG multigene family has been associated with cell transformation, tumor recurrence, and drug resistance. In addition to BAG overexpression, BAG members are also involved in many oncogenic protein–protein interactions (PPIs). As such, either the inhibition of overloading BAGs or of specific BAG–client protein interactions could have paramount therapeutic value. In this review, we will examine the role of each BAG family member in different malignancies, focusing on their modular structure, which enables interaction with a variety of proteins to exert their pro-tumorigenic role. Lastly, critical remarks on the unmet needs for proposing effective BAG inhibitors will be pointed out.
Source: Pharmacology and Therapeutics - Category: Drugs & Pharmacology Source Type: research